In today’s recent session, 1,232,288 shares of the Oncternal Therapeutics, Inc.(NASDAQ:ONCT) have been traded, and its beta is 1.73. Most recently the company’s share price was $8.93, and it changed around $0.27 or 0.03% from the last close, which brings the market valuation of the company to $444.77 Million. ONCT at last check was trading at a discount to its 52-week high of $9.45, offering almost -5.82% off that amount. The share price’s 52-week low was $1.49, which indicates that the recent value has risen by an impressive 83.31% since then. We note from Oncternal Therapeutics, Inc.’s average daily trading volume that its 10-day average is 1.44 Million shares, with the 3-month average coming to 1.58 Million.
Oncternal Therapeutics, Inc. stock received a consensus recommendation rating of Buy, based on a mean score of 2. If we narrow it down even further, the data shows that none out of 4 analysts rate the stock as a Sell; another but none rate it as Overweight. Among the rest, no body recommended ONCT as a Hold, whereas 4 deemed it a Buy, and no one rated it as Underweight. Oncternal Therapeutics, Inc. is expected to report earnings per share of -$0.1 for the current quarter.
Oncternal Therapeutics, Inc. (NASDAQ:ONCT): Trading Information Today
Instantly ONCT has been showing a green trend so far today with a performance of 3.12% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of $9.28- on Wednesday, Apr 07 increased the stock’s daily price by 3.45%. The company’s shares are currently up 0.83% year-to-date, but still up 0.1089 over the last five days. On the other hand, Oncternal Therapeutics, Inc. (NASDAQ:ONCT) is 0.66% up in the 30-day period. We can see from the shorts that 211.28 Million shares have been sold at a short interest cover period of 133.72 day(s).
The consensus price target as assigned by Wall Street analysts is $15, which translates to bears needing to increase their stock price by 67.97% from its current value. Analyst projections state that ONCT is forecast to be at a low of $9 and a high of $21. In order for the stock price to hit the forecast high, the stock would need to surge +135.16% from its current level, while the stock would need to crash 0.78% from its current level to reach the projected low.
Oncternal Therapeutics, Inc. (ONCT) projections and forecasts
Consensus estimates provided by 4 financial analysts predict the company will bring in an average of $1.11 Million in revenue for the current quarter. 4 analysts expect Oncternal Therapeutics, Inc. to make $1.24 Million in revenue for the quarter ending June 01, 2021. The company’s sales for the same quarters a year ago were $578Million and $623Million respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 92%. Forecasts for the next quarter put sales growth at 99%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 8.6%. Oncternal Therapeutics, Inc. earnings are expected to increase by 74.4% in 2021, but the outlook is negative 0% per year for the next five years.
Oncternal Therapeutics, Inc. (NASDAQ:ONCT)’s Biggest Investors
Upon looking at major shareholders, it appears that insiders hold 14.82% of Oncternal Therapeutics, Inc. shares, and 21.61% of them are in the hands of institutional investors. The stock currently has a share float of 25.37%. Oncternal Therapeutics, Inc. stock is held by 69 institutions, with Vanguard Group, Inc. (The) being the largest institutional investor. By Dec 30, 2020, it held 3.41% of the shares, which is about 1.68 Million shares worth $8.24 Million.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Ikarian Capital, LLC, with 2.09% or 1.03 Million shares worth $5.05 Million as of Dec 30, 2020, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 30, 2020. The former held 1121238 shares worth $5.49 Million, making up 2.28% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 483.12 Thousand shares worth around $2.37 Million, which represents about 0.98% of the total shares outstanding.